Atlas Trials

Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes

Clinical trial NCT01313533 · UNKNOWN

Trial details

NCT number
NCT01313533
Sponsor
St. Luke's Hospital, Chesterfield, Missouri
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Atherosclerosis
Start date
2015-03-01
Primary completion
2019-12-01
Enrollment
540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.